A Comparison of Outcomes After Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) Surgery Using Semiconductor Fabric Products

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-65
SponsorIllinois Center for Orthopaedic Research and Education

About this trial

The goal of this clinical trial is to determine the effect of semiconductor sleeves on the treatment of Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) arthroscopic surgery. The effect of the sleeves will be analyzed through patient reported and clinically measured outcomes. The main questions it aims to answer are:

* Do the semiconductor sleeves improve the functional outcomes compared to the placebo? * Will patients experience improved functional outcomes in a shorter period of time compared to the placebo?

Researchers will compare semiconductor fabric sleeves to a placebo (a look-alike sleeve that contains no semiconductor material) to see if the semiconductor fabric better treats ACL and ACL+meniscus surgical patients.

Participants will:

* Wear semiconductor or placebo leg sleeve for 4 weeks and knee sleeve for the following 12 weeks * Complete patient reported outcome surveys

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing ACL or ACL+Meniscus surgery

Age 16 - 65

Patients with Body Mass Index (BMI) <40

Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.

Disqualifiers

Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease

Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia

Patient has had prior surgical treatment of the knee in the last 5 years or injection treatment(s) in the last 6 months

Patient has chronic pain conditions unrelated to knee condition

Trial design

Design model

Parallel

Treatments tested in this trial

  • Semiconducting fabric sleeves

    Device

    This intervention includes semiconductor embedded sleeves that patients will wear for 4 months post-operatively.

  • Non-semiconducting fabric sleeves

    Device

    This intervention includes sleeves absent of semiconductors that will be worn for 4 months post-operatively.

Treatment groups

135 Participants
are divided into 3 treatment groups
Group A: Control GroupNo intervention 0 interventions
Group B: Semiconducting Fabric Sleeve GroupActive comparator 1 intervention
Group C: Placebo GroupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Range of motion

Measured extension and flexion values using a goniometer at baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year time points

Time frame
1 year

Secondary outcomes

1

Effusion Measurements

Effusion is measured by taking the circumference using a soft measuring tape at the following points: 1. Mid thigh: distance from palpation of Anterior Superior Iliac Spine (ASIS) to superior pole of patella, divided in half. (cm) 2. Knee: midpoint of the patella. (cm) 3. Mid calf: distance from top of fibular head to bottom of lateral malleolus, divided in half. (cm)

Time frame
1 year
2

Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires

Visual Analog Scale (VAS) - assess pain, It is a 0-100 scale. A higher score indicates greater pain intensity.

Time frame
1 year
3

Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires

International Knee Documentation Committee (IKDC) - assesses symptoms and function in daily living activities

Time frame
1 year
4

Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires

Knee Single Assessment Numeric Evaluation (SANE) - assess knee function on a scale of 0 to 100, with 100 representing normal function

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.